Diamond Biotechnology Co., Ltd
TWO: 6815.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Jiaxian Xie
- Employees
- 45
- Headquarters
- Taipei, Taiwan
- IPO year
- 2021
- Market cap
- NT$1.0B
- Website
- https://www.diamond-biotechnology.cc
Loading 6815…
Loading profile data…Frequently asked questions about 6815
What does Diamond Biotechnology Co., Ltd (6815.TWO) do?
Diamond Biotechnology Co., Ltd researches, develops, manufactures, and sells medical equipment and skincare products in Taiwan and internationally. The company offers skin care products under the Timera and Diamond Beauty brands. It also leases medical equipment. Diamond Biotechnology Co., Ltd was founded in 2014 and is based in Taipei, Taiwan.
Where does 6815.TWO trade?
Diamond Biotechnology Co., Ltd (6815.TWO) trades on the Taipei Exchange.
What sector is 6815.TWO in?
Diamond Biotechnology Co., Ltd (6815.TWO) operates in the Healthcare sector, specifically in the Medical - Equipment & Services industry.
Who is the CEO of Diamond Biotechnology Co., Ltd?
Jiaxian Xie is the chief executive officer of Diamond Biotechnology Co., Ltd (6815.TWO).
Where is Diamond Biotechnology Co., Ltd headquartered?
Diamond Biotechnology Co., Ltd is headquartered in Taiwan.
Does 6815.TWO pay a dividend?
Yes — Diamond Biotechnology Co., Ltd (6815.TWO) paid a trailing twelve-month dividend of TWD 0.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 6815.TWO go public?
Diamond Biotechnology Co., Ltd (6815.TWO) completed its initial public offering in 2021.